Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

Bullboard (CSE:AGN)

View:

Post by BlaineBorgon Jul 08, 2021 1:11am

Enrollment Rate Is 1.27 Patients Per Month For IPF & CC.

8 Months until full enrollment. 9 Months until final treatment. Fully compiled data readout... Who knows, but I suspect 1 year from now. You do the math. Christopher Moreau is pleased. I believe ...more

245

Discussion

Comment by hk1966on Jul 07, 2021 3:17pm

RE:"We are very pleased with the enrollment rate..."

This stock is seriously hitting the skids because of lack of mgmt credibility. Speaking of hitting the skids- Perhaps they can do everyone a favour and acquaint themselves with the CDC guidance on ...more

135

Discussion

Debt-Free and Thriving: Mining Company Reports 35% Revenue Growth in Q3 2024

posted Nov 12, 2024 9:00am by Mandalay Resources Corp.

"Revenue growth and free cash flow generation reflect our cost controls and prudent capital management while benefitting from high metal prices. As of the end of Q3 our cash balance was a healthy $54.7 million – more than doubling since December 2023 – and we have fully repaid the $20 million outstanding balance on our revolving credit facility, strengthening our liquidity and financial flexibility ...read more

Comment by BlaineBorgon Jul 07, 2021 10:15am

RE:RE:"We are very pleased with the enrollment rate..."

It's not relevant. What's relevant is the fact we all know the study is waaaay of track and the reason is because the CEO only has 6 locations across 2 countries. That's a needle in a ...more

161

Discussion

Comment by MoneyTalks22on Jul 07, 2021 9:27am

RE:"We are very pleased with the enrollment rate..."

so you are selling your shares then ??

150

Discussion

Post by BlaineBorgon Jul 07, 2021 9:17am

"We are very pleased with the enrollment rate..."

for IPF and CC? Seriously?! A 20 person study that was last due to report data in Q1 and Q2 2021 and the CEO is pleased? I mean that guy doesn't have a clue. BB

193

Discussion

Post by BlaineBorgon Jul 07, 2021 8:20am

From the ihub msg board to Christopher Moreau

Posted by smoki: CM you should share the letter you received from the FDA about Covid-19 and the date you received it ... you owe that much to your shareholders. __________________ That's one ...more

169

Post by MoneyTalks22on Jul 07, 2021 7:51am

so what is next ??

It seems to me that AGN chose not to go Phase 3 trial, not that FDA ruled against Ifenprodil, and the most outstanding reason to me is the projected trial size, costs and timellines needed. I am ...more

192

Comment by TheBearInTheWoodson Jul 06, 2021 7:37pm

RE:RE:RE:RE:RE:RE:RE:6 Fold Dilution To Chase After COVID-19. End Of Story.

Oh no Algernon, I mean Bithorse, I mean BlaineBorg what will I do without you? to that point, I promised at .30 that when this went to .12 I would leav this board, all the best. Good Day

107

Discussion

Comment by BlaineBorgon Jul 06, 2021 4:45pm

RE:RE:RE:RE:RE:RE:6 Fold Dilution To Chase After COVID-19. End Of Story.

You call what I do whatever you want. You simply are a nuts hanger on. As I've said you are talking about something you know nothing about. I guess that's your new outlandish theme here now ...more

Discussion

Comment by TheBearInTheWoodson Jul 06, 2021 3:22pm

RE:RE:RE:RE:RE:6 Fold Dilution To Chase After COVID-19. End Of Story.

To be clear , I believe that the chronic cough trial has had an outcome that has not been disclosed to the market. Rather negative or neutral outcome that has stalled the trial, there is no other ...more

Discussion

Comment by BlaineBorgon Jul 06, 2021 12:14pm

RE:RE:RE:RE:6 Fold Dilution To Chase After COVID-19. End Of Story.

Go back and read the posts you are chiming in on. You seem to not understand the bear was talking about the IPF and Chronic Cough study. He's conflating what happened today with something that has ...more

118

Discussion

Post by BlaineBorgon Jul 06, 2021 11:17am

GONE R THE DAYS THE CEO WOULD RUN TO BIOPUB WITH A FOLLOW UP

EOM BB

125

Post by CaboWabo5150on Jul 06, 2021 10:39am

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Bullboard (CSE:AGN)

Enrollment Rate Is 1.27 Patients Per Month For IPF & CC.

RE:"We are very pleased with the enrollment rate..."

Debt-Free and Thriving: Mining Company Reports 35% Revenue Growth in Q3 2024

RE:RE:"We are very pleased with the enrollment rate..."

RE:"We are very pleased with the enrollment rate..."

"We are very pleased with the enrollment rate..."

From the ihub msg board to Christopher Moreau

so what is next ??

RE:RE:RE:RE:RE:RE:RE:6 Fold Dilution To Chase After COVID-19. End Of Story.

RE:RE:RE:RE:RE:RE:6 Fold Dilution To Chase After COVID-19. End Of Story.

RE:RE:RE:RE:RE:6 Fold Dilution To Chase After COVID-19. End Of Story.

RE:RE:RE:RE:6 Fold Dilution To Chase After COVID-19. End Of Story.

GONE R THE DAYS THE CEO WOULD RUN TO BIOPUB WITH A FOLLOW UP

We Were Fleeced...

THIS IS THE "INFLECTION POINT" THE CEO BLABBED ABOUT - EOM

Does Anyone Here Thiunk It's Coincidental The Sister Company

Featured News Links

Gold, growth and sustainability in focus for this resource company

Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits

Star Diamond Corporation Announces Third Quarter 2024 Results

Explained: The Psychology of Options Trading with Practical Tips

Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023

Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.

Meet the Top 5 Best Online Brokerages in Canada

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (CSE:AGN)

Featured News Links